Despite Stepan's stock rise, its inconsistent financials and...

Despite Stepan's stock rise, its inconsistent financials and low ROE may impact share price momentum. Low earnings growth despite high profit retention suggests investors may not benefit from reinvestment. Future payout ratio is expected to rise to 33%, indicating a potential strategy shift.